Search

Switzerland: Management Structure Roland Diggelmann, CEO Diagnostics Division Quits Roche

| Editor: Ahlam Rais

With Roland Diggelmann exiting the firm, Michael Heuer will be in charge of holding the ad interim leadership of Roche's Diagnostics Division until a successor is appointed.

Roland Diggelmann will be leaving Roche to pursue his career outside of the company effective September 30, 2018.
Roland Diggelmann will be leaving Roche to pursue his career outside of the company effective September 30, 2018.
(Source: F. Hoffmann-La Roche)

Basel/Switzerland – Roche has recently announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective September 30, 2018. Until a successor is named, Michael Heuer, currently Region Head Europe, Middle East, Africa, and Latin America for Roche Diagnostics will assume the ad interim leadership of Roche's Diagnostics Division and become a member of the Corporate Executive Committee.

Roland Diggelmann started his career with Roche in 2008 and was previously Region Head Asia Pacific for Roche Diagnostics before assuming his current role in 2012. Michael Heuer joined Boehringer Mannheim in 1983 and was appointed to his current role in 2008.

Following Roche's acquisition of Boehringer Mannheim in 1998, he held various leadership positions in sales, marketing, and product development in Germany, Austria, and the United States. Prior to his current role, Michael was Sub-region Head covering Central and Eastern Europe, Turkey, Greece and South Africa, and previous to that Head of the Roche Near Patient Testing Business Area. Michael holds a PhD in Chemistry from the University of Kiel in Germany.

(ID:45471060)